Reproductive Life Planning for Women With Mental Illness
CompletedNAResults postedLast updated 22 April 2022
What this trial tests
NA trial testing Reproductive Life Planning-Mental Health (RLP-MH) Intervention in Psychotic Disorders in 40 participants. Completed in 28 February 2021.
Adults 18 to 40, female only, with Psychotic Disorders or Mood Disorders. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Reproductive Life Goal Behavioral IntentionsPrimary· Baseline to 2-Month Post-Intervention (~2 months)
The Reproductive Life Goal Behavioral Intentions scale was used to measure self-reported intentions to engage in behavior to address one's reproductive life goals. A total score was calculated by taking the sum of the responses to the items. The average total score across participants is reported (range = 1 to 5) with higher scores indicating greater intentions to engage in behaviors to address one's reproductive life goals.
Baseline
Group
Value
95% CI
Reproductive Life Planning-Mental Health Intervention
3.6
± 1.3
Written Materials on Reproductive Life Planning
2.7
± 1.5
2-Month Post Intervention
Group
Value
95% CI
Reproductive Life Planning-Mental Health Intervention
3.3
± 1.4
Written Materials on Reproductive Life Planning
3.0
± 1.7
Reproductive Health Decisional Self-EfficacyPrimary· Baseline to 2-Month Post-Intervention (~2 months)
The Reproductive Health Decisional Self-Efficacy scale was used to measures expectations or beliefs about one's ability to engage in behaviors that help in making reproductive life decisions. A total score is calculated by taking the sum of response to the items (range = 0 to 44) with higher scores indicating greater decisional self-efficacy.
Baseline
Group
Value
95% CI
Reproductive Life Planning-Mental Health Intervention
35.7
± 11.9
Written Materials on Reproductive Life Planning
33.9
± 8.8
2-Month Post Intervention
Group
Value
95% CI
Reproductive Life Planning-Mental Health Intervention
40.7
± 3.4
Written Materials on Reproductive Life Planning
38.7
± 6.0
Attitudes Towards Reproductive Life PlanningPrimary· Baseline to 2-Month Post-Intervention (~2 months)
The Attitudes Towards Reproductive Life Planning developed for this study will be used to measure attitudes towards reproductive life planning and goal setting across several domains key to effective reproductive life planning. A total score is calculated by taking the sum of responses to the items (range = 7 to 49) with higher scores indicating more positive/favorable attitudes towards reproductive life planning.
Baseline
Group
Value
95% CI
Reproductive Life Planning-Mental Health Intervention
38.1
± 12.5
Written Materials on Reproductive Life Planning
42.2
± 10.6
2-Month Post Intervention
Group
Value
95% CI
Reproductive Life Planning-Mental Health Intervention
38.9
± 10.8
Written Materials on Reproductive Life Planning
39.4
± 11.6
Sponsor's own description
Women represent the fastest growing population within the VHA. Many are of reproductive age and experience mental health concerns. Women with mental illness are at greater risk for unplanned pregnancy and poor pregnancy outcomes due to factors related to mental health and mental health treatment. Similarly, mental health concerns (e.g., impact of pregnancy on mental illness, psychiatric medications and pregnancy) can affect reproductive life goals and plans. Reproductive life planning (RLP) interventions that include considerations and concerns women Veterans with mental illness face are needed. The investigators adapted existing RLP materials to create an interactive, individualized, client-centered RLP intervention designed to help women Veterans with mental illness develop a mental health-informed reproductive life plan and reproductive life goals (RLP-MH). The current study aims to determine if the RLP-MH intervention is feasible and acceptable to women Veterans and if it increases engagement in behaviors to address RLP goals.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
NCT07460453 — Racial Disparities in the Expression of Paranoia
· NA
· recruiting
NCT06758414 — CBT-CP for Veterans With SMI
· NA
· recruiting
NCT07395206 — Acceptability, Feasibility and Preliminary Outcomes of the Kiso Mind App for Outpatients With Schizophrenia Spectrum Dis
· NA
· recruiting
NCT07360665 — Multimodal Physical Exercise Program (Physical Exercise for Psychosis) for People With Psychosis Treated With Long-Actin
· NA
· recruiting
NCT06993662 — The Combination of Pharmacotherapy and Cognitive Behavioral Psychotherapy Under the Recovery Perspective.
· Phase 1
· active not recruiting
Other VA Office of Research and Development trials
Trials by the same sponsor.
NCT07456150 — Personalizing Veteran Pain Care: Adapting Coaching Interventions to Support Maintenance of Self-Care
· Phase 1
· not yet recruiting
NCT06746727 — The Development of a Transdiagnostic Intervention to Improve Social Functioning and Intimate Relationships Among Veteran
· NA
· not yet recruiting
NCT07362576 — Perinatal Peer Support for Veterans With Serious Mental Illness
· NA
· not yet recruiting
NCT06766331 — Integrated Care Versus Usual Care for Opioid Use Disorder and Infectious Diseases in Veterans
· NA
· not yet recruiting
NCT07397195 — ACT for Veterans With IBD and Mental Health Challenges
· NA
· not yet recruiting
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by VA Office of Research and Development
Last refreshed: 22 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03969589.